Press releaseGlobe Newswire
Sol Gel Technologies
SLGL · NASDAQ
$65.81+$0.83 (+1.28%)TodayMarket closed ·
Prev close $64.98
Latest news
- Press releaseGlobe Newswire
Sol-Gel Technologies Announces Last Patient Last Visit in Pivotal Phase 3 Clinical Trial of SGT-610 in Gorlin Syndrome
- News
Sol-Gel Technologies Q2 EPS $(1.13) Beats $(2.31) Estimate, Sales $591.000K Beat $75.000K Estimate
- Press releaseGlobe Newswire
Sol-Gel Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
- Press releaseGlobe Newswire
Sol-Gel Reports First Quarter 2026 Financial Results and Provides Corporate Updates
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- Press releaseGlobe Newswire
Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering
- Press releaseGlobe Newswire
Sol-Gel Files Annual Report on Form 20-F for the Year Ended December 31, 2025
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- NewsVandana Singh
Why Is Small Cap Sol-Gel Tech Stock Falling Today?
- Press releaseGlobe Newswire
Sol-Gel Provides Update Following Unblinding of Phase 1b Study of SGT-210 in Darier Disease
- Press releaseGlobe Newswire
Sol-Gel Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- Press releaseGlobe Newswire
Sol-Gel Announces Health Canada Approval of EPSOLAY®
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- News
Sol-Gel Technologies Q2 EPS $4.17 Beats $(0.07) Estimate, Sales $17.261M Beat $2.900M Estimate
- Press releaseGlobe Newswire
Sol-Gel Reports Second Quarter 2025 Financial Results and Provides Corporate Updates
- NewsAvi Kapoor
US Stocks Gain, Nasdaq Surges Over 100 Points
- Press releaseGlobe Newswire
Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
- NewsAvi Kapoor
Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.